Accurate biomarker status

 

for

optimal outcomes

iD.Lung: learn about biomarker
testing in lung cancer

 

iD.Lung is an online resource providing up-to-date information on biomarker testing in patients with lung cancer.

 

Understand why testing is important and the different testing methods available, and find useful guidance on who, when and how to test.

 

iD.Lung: helping you achieve accurate biomarker status for optimal outcomes.

This content is not currently available for your device.

X


Philip Jewsbury, Senior Project Director in Oncology iMed at AstraZeneca discusses how advanced scientific research and targeted therapies are changing treatments for lung cancer.

A website exploring why EGFR mutation testing is important in the diagnosis and treatment of advanced NSCLC

FIND OUT MORE

An online resource for understanding the benefits of BRCA testing at diagnosis of ovarian cancer

FIND OUT MORE